Dr. Gil Kliman joined InterWest's life sciences team in 1996. He invests in a broad array of life sciences opportunities with a special interest in ophthalmology and medical devices. He is a board member of Autonomic Technologies, Epocrates (EPOC), Glaukos, ODTx, Restoration Robotics, and ReVision Optics.

Prior to InterWest, Dr. Kliman was a healthcare investor at TA Associates and at Norwest Venture Capital. As a practicing ophthalmologist he was the former west coast director of LCA Vision, and served as an assistant professor at Tufts New England Eye Center.

Dr. Kliman has a B.A. from Harvard University. He received an M.D. from the University of Pennsylvania and an M.B.A. from Stanford University. He also serves as a National Trustee for the Foundation Fighting Blindness.

Previous Representative Investments

INC Research – acquired by Avista Capital Partners
IntraLase (ILSE) – acquired by Advanced Medical Optics (EYE)
LenSx Lasers – acquired by Alcon
Spinal Dynamics – acquired by Medtronic (MDT)
Spiration – acquired by Olympus Medical

A Word from Gil

Dr. Gil Kliman, General Partner "Over the last 20 years I have had the privilege of diverse life experiences as a laser researcher, practicing physician, startup company founder, and technology venture capitalist. I most enjoy being on the front edge of new technology waves, looking over the horizon for non-obvious opportunities... What I find exciting is working alongside visionary entrepreneurs, thinking outside the box, and helping to identify creative strategies to make pioneering ventures even more successful."